Attends Limited
Registered name: ATTENDS LIMITED
Part of Zither L Investments Sarl groupAttends Limited made £35.9m revenue and £635k profit in the year to 31 Dec 2024.
Attends Limited’s revenue grew 15% to £35.9m in the year to 31 Dec 2024, with £635k profit and 23 employees. The company is classified under “wholesale of pharmaceutical goods” and is based in Wakefield; we hold 2 years of its filed accounts.
- Status
- Active
- Location
- Wakefield, Yorkshire and The Humber
- Age
- 27 yrs · since 1999
- Type
- Private Limited Company
Part of a group. The filing indicates this company sits within a group structure, so its results may depend on intra-group trading and it may be hard to replicate independently.
Key figures
Badges are automated estimates derived from the filed figures — not statements of fact about the company.
Financial history
| Year to | 31 Dec 2023 | 31 Dec 2024 |
|---|---|---|
| Disclosure | Full P&L | Full P&L |
| Profit & loss | ||
| Revenue (turnover) | £31.3m | £35.9m |
| Cost of sales | £25.9m | £30.1m |
| Gross profit | £5.3m | £5.8m |
| Operating profit | £485k | £531k |
| Profit before tax | £554k | £851k |
| Profit after tax | £554k | £635k |
| Profit (best available) | £554k | £635k |
| Employees (average) | 24 | 23 |
| Ratios | ||
| Profit margin | 1.8% | 1.8% |
| Gross margin | 17.1% | 16.2% |
| Revenue per employee | £1.3m | £1.6m |
| Profit per employee | £23.1k | £27.6k |
| Growth (year on year) | ||
| Revenue growth | — | ▲14.9% |
| Profit growth | — | ▲14.7% |
| Headcount growth | — | ▼4.2% |
| Balance sheet — indirect signals, not revenue | ||
| Cash at bank | £395k | £1.9m |
| Net assets | £7.9m | £8.5m |
| Fixed assets | £4.3k | £7k |
| Current assets | £9.3m | £11.9m |
| Debtors | £4.3m | £6.8m |
| Deferred income | £230k | £238k |
| Source | FullAccounts · bulk data Sep 2025 | FullAccounts · bulk data Sep 2025 |
How the business works
- Profit margin
- 1.8%
- Profit ÷ revenue.
- Gross margin
- 16.2%
- Gross profit ÷ revenue. High for software and services.
- Revenue per employee
- £1.6m
- Revenue ÷ average employees.
- Profit per employee
- £27.6k
- Profit ÷ average employees.
- Cash conversion
- —
- Cash generated from operations ÷ operating profit. Needs a cash-flow statement.
- Fixed assets ÷ revenue
- 0%
- Capital intensity. Low = capital-light, cheaper to start.
- Deferred income ÷ revenue
- 0.7%
- Customers paying upfront (subscriptions, deposits). Approximate when combined with accruals.
- Debtors ÷ revenue
- 18.8%
- Money owed by customers. Low = customers pay quickly.
Balance-sheet signals
Year-on-year changes in filed balance-sheet items. They can hint at momentum (or investment) but are not revenue or profit and must not be read as such.
- Net assets
- ▲8%
- Now £8.5m
- Cash at bank
- ▲385%
- Now £1.9m
- Headcount
- ▼4%
- Now 23
- Deferred income
- ▲3%
- Now £238k
- Fixed assets
- ▲61%
- Now £7k
Deferred income is reported together with accruals in this filing (“accruals and deferred income”), so it is an approximate signal only.
Group structure
Ownership chain
- Zither L Investments Sarl (registered outside the UK register)ultimate parent75–100%
- Attends Limitedthis company
Bands show the share of ownership each company holds in the one below it.
Minority corporate shareholders
- Journey Personal Care Holdings Ltd. (registered outside the UK register)
From the Persons with Significant Control register (corporate controllers only).
Similar profitable businesses
- New England Biolabs (U.K.) LimitedHitchin · Wholesale of pharmaceutical goods
- Revenue
- £36m
- Profit
- £1.8m
- Staff
- 44
- Knox Pharmaceuticals LimitedRipon · Wholesale of pharmaceutical goods
- Revenue
- £37.1m
- Profit
- £3.8m
- Staff
- 38
- Target Healthcare LimitedGlasgow · Wholesale of pharmaceutical goods
- Revenue
- £37.3m
- Profit
- £2.2m
- Staff
- 131
- Beta Pharmaceuticals LimitedWitham · Wholesale of pharmaceutical goods
- Revenue
- £34.3m
- Profit
- £120k
- Staff
- 61
- Dexcel-Pharma LimitedCoventry · Wholesale of pharmaceutical goods
- Revenue
- £39.1m
- Profit
- £3.7m
- Staff
- 25
- Ims Euro LimitedStockport · Wholesale of pharmaceutical goods
- Revenue
- £32.9m
- Profit
- £5.5m
- Staff
- 83
Sources
Latest figures from FullAccounts for the year to 31 Dec 2024 (profit £635k), from the Companies House accounts bulk data published Sep 2025. Spotted an error? Request a correction.
Contains public sector information from Companies House licensed under the Open Government Licence v3.0. Data from Companies House, © Crown copyright. View the licence.